A front-line window of opportunity phase II study of sorafenib in patients with advanced non-small cell lung cancer.
- Citation:
- J Clin Oncol vol 25 (18s) 396s abstr 7547
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 270
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. A. Adjei J. R. Molina S. L. Hillman R. F. Luyun N. F. Reuter K. M. Rowland Jr J. R. Jett S. J. Mandrekar S. E. Schild
- Networks:
- Study
- NCCTG-N0326
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: